National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Cystic Fibrosis trials

The registry lists 11 Cystic Fibrosis studies with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Natural History of Noncirrhotic Portal HypertensionRecruitingNCT02417740
• Longitudinal Assessment of Transient Elastography in Cystic FibrosisCompletedNCT03001388
• MRI to Characterize and Predict CF Liver Disease in PUSH CohortCompletedNCT02979340
• Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic FibrosisCompletedNCT01144507
• Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)CompletedNCT00082238Not applicable
• Diabetes Therapy to Improve BMI and Lung Function in CFCompletedNCT00072904Phase 3
• Benefits and Risks of Newborn Screening for Cystic FibrosisCompletedNCT00014950Not applicable
• A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic FibrosisCompletedNCT00006280Phase 2
• Behavioral Treatment of Weight Gain in CFCompletedNCT00006169Phase 3
• Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic FibrosisCompletedNCT00004533Phase 1
• Diagnosis and Treatment of Patients With Cystic FibrosisTerminatedNCT00001223